Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1
- PMID: 10428898
- PMCID: PMC89376
- DOI: 10.1128/AAC.43.8.1817
Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1
Erratum in
- Antimicrob Agents Chemother 2000 Apr;44(4):1119
Comment in
-
Antiretroviral-drug concentrations in semen.Antimicrob Agents Chemother. 2000 Apr;44(4):1117-8. doi: 10.1128/AAC.44.4.1117-1118.2000. Antimicrob Agents Chemother. 2000. PMID: 10799009 Free PMC article. No abstract available.
References
-
- Anderson D J, O’Brien T R, Politch J A, Martinez A, Seage III G R, Padian N, Horsburgh R, Jr, Mayer K H. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA. 1992;267:2769–2774. - PubMed
-
- Armstrong J R, Cook F E, Robinson J R. Concentration of antibiotic and chemotherapeutic agents in the ejaculum. J Urol. 1968;100:72–76. - PubMed
-
- Aumuller G, Seitz J, Lilja H, Abrahamsson P A, von der Kammer H, Scheit K H. Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles. Prostate. 1990;17:31–40. - PubMed
-
- Baggot J D. Clinical pharmacokinetics in veterinary medicine. Clin Pharmacokinet. 1992;22:254–273. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical